Page last updated: 2024-08-25

tocophersolan and Carcinoma, Non-Small Cell Lung

tocophersolan has been researched along with Carcinoma, Non-Small Cell Lung in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (71.43)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Chinni, S; Kala, SG1
Lin, X; Wang, H; Wu, Y1
Bao, Y; Chu, Q; Tan, S; Wu, T; Wu, Y; Zhang, Z; Zhuang, X1
Hou, J; Jia, X; Lv, H; Sun, E; Wang, J; Xin, J; Yan, H; Yang, L; Zhang, Z1
Jia, X; Song, J; Wei, P; Yan, H; Zhang, Z1
Jia, X; Song, J; Yan, H; Zhang, Z1
Gill, KK; Kaddoumi, A; Nazzal, S1

Other Studies

7 other study(ies) available for tocophersolan and Carcinoma, Non-Small Cell Lung

ArticleYear
Bioavailability enhancement of vitamin E TPGS liposomes of nintedanib esylate: formulation optimization, cytotoxicity and pharmacokinetic studies.
    Drug delivery and translational research, 2022, Volume: 12, Issue:11

    Topics: Animals; Biological Availability; Carcinoma, Non-Small-Cell Lung; Drug Carriers; Indoles; Liposomes; Lung Neoplasms; Male; Particle Size; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Succinates; Vitamin E

2022
Crizotinib loaded polydopamine-polylactide-TPGS nanoparticles in targeted therapy for non-small cell lung cancer.
    Medical oncology (Northwood, London, England), 2022, Dec-02, Volume: 40, Issue:1

    Topics: Carcinoma, Non-Small-Cell Lung; Chemical and Drug Induced Liver Injury; Crizotinib; Humans; Lung Neoplasms; Nanoparticles

2022
D-α-tocopherol polyethylene glycol succinate-based derivative nanoparticles as a novel carrier for paclitaxel delivery.
    International journal of nanomedicine, 2015, Volume: 10

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Drug Delivery Systems; Female; Humans; Lung Neoplasms; MCF-7 Cells; Mice; Micelles; Nanoparticles; Ovarian Neoplasms; Paclitaxel; Particle Size; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Sarcoma; Succinates; Vitamin E

2015
TPGS-modified liposomes for the delivery of ginsenoside compound K against non-small cell lung cancer: formulation design and its evaluation in vitro and in vivo.
    The Journal of pharmacy and pharmacology, 2016, Volume: 68, Issue:9

    Topics: A549 Cells; Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Drug Carriers; Ginsenosides; Liposomes; Male; Mice, Nude; Panax; Phospholipids; Phytotherapy; Plant Extracts; Polyethylene Glycols; Vitamin E

2016
Enhanced anticancer activity in vitro and in vivo of luteolin incorporated into long-circulating micelles based on DSPE-PEG2000 and TPGS.
    The Journal of pharmacy and pharmacology, 2016, Volume: 68, Issue:10

    Topics: A549 Cells; alpha-Tocopherol; Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Drug Carriers; Drug Delivery Systems; Drug Liberation; Lung Neoplasms; Luteolin; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Micelles; Particle Size; Phosphatidylethanolamines; Polyethylene Glycols; Vitamin E

2016
Hyaluronic acid-modified didecyldimethylammonium bromide/ d-a-tocopheryl polyethylene glycol succinate mixed micelles for delivery of baohuoside I against non-small cell lung cancer: in vitro and in vivo evaluation.
    Drug delivery, 2017, Volume: 24, Issue:1

    Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Flavonoids; Humans; Hyaluronic Acid; Inhibitory Concentration 50; Injections, Intravenous; Lung Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Micelles; Paclitaxel; Quaternary Ammonium Compounds; Solubility; Surface Properties; Technology, Pharmaceutical; Time Factors; Vitamin E; Xenograft Model Antitumor Assays

2017
Mixed micelles of PEG(2000)-DSPE and vitamin-E TPGS for concurrent delivery of paclitaxel and parthenolide: enhanced chemosenstization and antitumor efficacy against non-small cell lung cancer (NSCLC) cell lines.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2012, May-12, Volume: 46, Issue:1-2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Drug Carriers; Humans; Inhibitory Concentration 50; Lung Neoplasms; Magnetic Resonance Spectroscopy; Micelles; Paclitaxel; Particle Size; Phosphatidylethanolamines; Polyethylene Glycols; Sesquiterpenes; Vitamin E

2012